SXTP - 60 DEGREES PHARMACEUTICALS, INC.
IEX Last Trade
1.32
0 0%
Share volume: 500
Last Updated: Fri 27 Dec 2024 08:14:02 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$1.32
0.00
0.00%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
15.52%
1 Month
22.94%
3 Months
5.51%
6 Months
396.30%
1 Year
13.56%
2 Year
-71.37%
Key data
Stock price
$1.32
DAY RANGE
$1.27 - $1.32
52 WEEK RANGE
$0.10 - $2.54
52 WEEK CHANGE
$31.37
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Geoffrey Dow
Region: US
Website: 60degreespharma.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: 60degreespharma.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
We are a growth-oriented specialty pharmaceutical company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. Our principal executive offices are located at 1025 Connecticut Avenue NW Suite 1000, Washington, D.C.
Recent news